Newsroom

April 1, 2020

Venclose eclipses 2018 results, patient success

Vein Therapy News

View Article

December 6, 2019

Venclose brings in $27 million Series C to market venous reflux solution

MedCity News

View Article

December 4, 2019

Venclose Closes $27 Million Series C Funding

View Press Release

April 1, 2019

A New RF System: Venclose’s new radiofrequency technology outperforms legacy systems

Vein Therapy News

View Article

January 30, 2019

Venclose and Viant Partner to Deliver Next-Generation Vein Treatment Solutions

View Press Release

July 11, 2018

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

View Press Release

March 19, 2018

Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System

View Press Release